Type 2 & other diabetes

Longitudinal associations of cumulative and repeated-measure patterns of insulin resistance surrogate indices with biological age acceleration and incident cardiovascular disease across cardiovascular-kidney-metabolic syndrome stages 0–3: evidence from CHARLS 2011–2020

Cardiovasc DiabetolPublished Prospective cohort study

Authors' conclusion

Sustained IR burden and unfavorable longitudinal IR patterns are linked to higher CVD risk in CKM stages 0-3, partly through accelerated biological aging. Integrating longitudinal IR profiling with aging metrics may sharpen early risk stratification and support scalable prevention targeting upstream metabolic drivers.

Study context

Population
Participants with cardiovascular-kidney-metabolic (CKM) syndrome stages 0–3, CHARLS 2011–2020
Participants
3,948 participants
Exposure
Cumulative and longitudinal pattern groups of 12 insulin resistance (IR) surrogate indices and incident cardiovascular disease (CVD)
Outcome
Incident CVD
Methodological detailslongitudinal, Fine-Gray competing risk models, K-means-derived pattern groups, mediation analyses
  • Longitudinal
  • Fine-Gray competing risk models
  • K-means-derived pattern groups
  • Mediation analyses

Main finding

As reported in the abstract

Developed incident CVD

756

19.1%

Observational data: associations, not effects.

Further findings

Predictive performance for CVD risk

Cumulative eGDR AUC (all DeLong P < 0.05 vs other indices)
0.613
Cumulative eGDR top contributor by both WQS and Qgcomp analyses

Mediation by biological age acceleration

KDM-BioAgeAccel partially mediated several IR-CVD associations, up to
45.8%
Light-BioAgeAccel partially mediated several IR-CVD associations, up to
25.9%

Original publication

Longitudinal associations of cumulative and repeated-measure patterns of insulin resistance surrogate indices with biological age acceleration and incident cardiovascular disease across cardiovascular-kidney-metabolic syndrome stages 0–3: evidence from CHARLS 2011–2020. Cardiovasc Diabetol. Published 16 May 2026. doi:10.1186/s12933-026-03206-z

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.